Search

Your search keyword '"Jabado, Nada"' showing total 62 results

Search Constraints

Start Over You searched for: Author "Jabado, Nada" Remove constraint Author: "Jabado, Nada" Database Springer Nature Journals Remove constraint Database: Springer Nature Journals
62 results on '"Jabado, Nada"'

Search Results

3. Impact of trametinib on the neuropsychological profile of NF1 patients

4. Immune landscape of oncohistone-mutant gliomas reveals diverse myeloid populations and tumor-promoting function

5. Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma

6. The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial

7. Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial

9. MAPK inhibitor sensitivity scores predict sensitivity driven by the immune infiltration in pediatric low-grade gliomas

10. Using comprehensive genomic and functional analyses for resolving genotype–phenotype mismatches in children with suspected CMMRD in Lebanon: an IRRDC study

11. K27M in canonical and noncanonical H3 variants occurs in distinct oligodendroglial cell lineages in brain midline gliomas

12. Failure of human rhombic lip differentiation underlies medulloblastoma formation

13. Structural variants shape driver combinations and outcomes in pediatric high-grade glioma

14. Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenome

15. Detection and genomic analysis of BRAF fusions in Juvenile Pilocytic Astrocytoma through the combination and integration of multi-omic data

16. Inhibition of nuclear export restores nuclear localization and residual tumor suppressor function of truncated SMARCB1/INI1 protein in a molecular subset of atypical teratoid/rhabdoid tumors

17. Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation

19. The transcriptional landscape of Shh medulloblastoma

20. Pontine gliomas a 10-year population-based study: a report from The Canadian Paediatric Brain Tumour Consortium (CPBTC)

21. Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study

22. YAP1-fusions in pediatric NF2-wildtype meningioma

23. Stalled developmental programs at the root of pediatric brain tumors

24. The molecular landscape of ETMR at diagnosis and relapse

25. Author Correction: Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenome

27. Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma

28. The histone mark H3K36me2 recruits DNMT3A and shapes the intergenic DNA methylation landscape

30. Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome

32. A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01

34. Methylome analysis and whole-exome sequencing reveal that brain tumors associated with encephalocraniocutaneous lipomatosis are midline pilocytic astrocytomas

35. DNA methylation-based classification of central nervous system tumours

37. DNA methylation signature is prognostic of choroid plexus tumor aggressiveness

38. H3K27M induces defective chromatin spread of PRC2-mediated repressive H3K27me2/me3 and is essential for glioma tumorigenesis

39. TRPV4 and KRAS and FGFR1 gain-of-function mutations drive giant cell lesions of the jaw

40. Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome

41. The whole-genome landscape of medulloblastoma subtypes

42. Atypical teratoid rhabdoid tumor in the first year of life: the Canadian ATRT registry experience and review of the literature

45. Germline and somatic FGFR1 abnormalities in dysembryoplastic neuroepithelial tumors

47. Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers

48. The role of resection alone in select children with intracranial ependymoma: the Canadian Pediatric Brain Tumour Consortium experience

49. Author Correction: Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome

50. Alternative lengthening of telomeres is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumors

Catalog

Books, media, physical & digital resources